Cargando…
Does Widespread Use of Hydroxychloroquine Reduce the Transmissibility of SARS-CoV-2 / COVID-19? An Ecological Correlational Study
BACKGROUND: At the beginning of the coronavirus disease (COVID-19) pandemic, hydroxychloroquine (HCQ) was widely used as a possible antiviral agent. Current knowledge indicates that HCQ has little or no effect on individual clinical outcomes of COVID-19, but populational effects on disease transmiss...
Autor principal: | Neves, Fabricio Souza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682993/ https://www.ncbi.nlm.nih.gov/pubmed/37218196 http://dx.doi.org/10.2174/1871526523666230522114836 |
Ejemplares similares
-
Safety and efficacy of hydroxychloroquine as prophylactic against COVID-19 in healthcare workers: a meta-analysis of randomised clinical trials
por: Hong, Hwanhee, et al.
Publicado: (2023) -
Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomised trials
por: Izcovich, Ariel, et al.
Publicado: (2022) -
Impact of non-pharmaceutical interventions for reducing transmission of COVID-19: a systematic review and meta-analysis protocol
por: Regmi, Krishna, et al.
Publicado: (2020) -
Repurposing povidone-iodine to reduce the risk of SARS-CoV-2 infection and transmission: a narrative review
por: Lim, Nicole-Ann, et al.
Publicado: (2022) -
Reduced Community-acquired Respiratory Virus Infection, but Not Non–virus Infection, in Lung Transplant Recipients During Government-mandated Public Health Measures to Reduce COVID-19 Transmission
por: Keller, Brian C., et al.
Publicado: (2023)